01.03.2011 • NewsDow ChemicalCitigroupPeople

Andrew Liveris To Leave Citi Board

Dow Chemicals Andrew Liveris will not stand for re-election Citibanks annual...
Dow Chemical's Andrew Liveris will not stand for re-election Citibank's annual meeting on April 21.

Dow Chemical Chief Executive Andrew Liveris will leave Citigroup board of directors in April, the bank said in a regulatory filing on Monday. Liveris will not stand for re-election at the bank's annual meeting on April 21, according to the filing.

The head of the largest U.S. chemical maker, Liveris joined Citigroup's board in 2005 and was one of the few remaining directors from before the financial crisis. He is also on the IBM board of directors.

Regulators pressed the bank to add more directors with financial experience during the crisis, as massive losses forced Citigroup to take $45 billion in U.S. bailout funds. Last month, the bank reported its first full-year profit since 2007.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.